Ethamsylate Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mg/mL or 500 mg/2 mL ampoules
Reference Brands: Dicynone (EU)
Category: Women's Health
Ethamsylate injection (250 mg/mL, 500 mg/2 mL ampoules), a capillary haemostatic for surgical and gynaecological bleeding, offered to hospital buyers, importers and distributors in markets where it is registered.
Manufacture or export Ethamsylate Injection? List it or send an offer →
Product Description:
Ethamsylate, also spelt etamsylate, is a synthetic haemostatic agent. It is thought to act on the capillary wall and on platelets, improving platelet adhesion and capillary resistance, rather than by changing clotting factors or blocking fibrinolysis. This page covers the solution for injection at 250 mg/mL, the same concentration as a 500 mg/2 mL ampoule. The injection serves patients who cannot take tablets or need a quicker onset, as in theatre, and is given by slow intravenous or intramuscular injection.
It is used for capillary bleeding during and after surgery, including gynaecological, ENT and dental procedures, and in some markets for heavy menstrual bleeding. It is an adjunct, never a substitute for surgical control of bleeding or for blood products, and for postpartum haemorrhage WHO guidance favours tranexamic acid. It is contraindicated in acute porphyria. Pharmacists check the excipient list for sulfite antioxidants and discard any solution that has changed colour.
Sourcing notes. Ethamsylate is registered in India and a number of other markets but is not approved in the United States, so confirm national registration before quoting. It is prescription-only. Expect a CTD or ACTD dossier with stability data for the zone of use, including zone IVb for hot humid markets. Ampoules stay in the outer carton away from light; no cold chain is normally needed. Ask for a CoA per batch covering assay, sterility and bacterial endotoxins, plus the GMP certificate and a CoPP. State concentration, ampoule volume, ampoules per box and any sulfite-free need.
Ethamsylate Injection — third party manufacturing & bulk supply
Ethamsylate Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ethamsylate Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ethamsylate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ethamsylate Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Ethamsylate Injection is used to prevent and control bleeding in various conditions such as abnormal uterine bleeding, surgical procedures, dental extractions, and capillary bleeding disorders. It helps reduce blood loss and improves capillary stability.
Ethamsylate Injection is made from the active pharmaceutical ingredient Ethamsylate, a synthetic hemostatic compound that works by improving platelet adhesion and strengthening capillary walls.
The common trade names of Ethamsylate Injection include Dicynone, Dicynene, Etham, Hemolet, and Sylate Injection, depending on the region and manufacturer.
Ethamsylate Injection is manufactured by several pharmaceutical companies worldwide. One of the well-known brands, Dicynone, is originally associated with companies like OM Pharma (now part of larger pharmaceutical groups), while many Indian manufacturers also produce it.
The generic name of Ethamsylate Injection is Ethamsylate.
The brand names of Ethamsylate Injection include Dicynone, Dicynene, Etham, Hemolet, and Sylate Injection.
Ethamsylate Injection is manufactured in multiple countries including India, several European countries, and other global pharmaceutical manufacturing hubs, depending on the company producing the product.
Related Products
Liothyronine Tablet
Strength:
5 mcg, 25 mcg, 50 mcg
Form: Oral tablets
Reference Brands: Cytomel®(US); Tertroxin®(EU)
View DetailsMethylergometrine Maleate Injection
Strength:
0.2 mg/mL, 0.2 mg
Form: Injection and Tablets
Reference Brands: Methergine® (EU & US)
View DetailsMedroxyprogesterone Acetate Suspension
Strength:
150 mg/mL, 400 mg/mL
Form: Injection
Reference Brands: Depo-Provera®(US & EU); Depo-Progestin®(EU)
View DetailsLevonorgestrel .
Strength:
Tablet: 1.5 mg; IUD- 52 mg,19.5 mg
Form: Tablet and IUD
Reference Brands: Plan B One-Step®(US), NorLevo®(EU), Mirena®, Kyleena®(EU & US)
View DetailsGanirelix Acetate
Strength:
0.25 mg/0.5 mL
Form: injection (prefilled syringe)
Reference Brands: Antagon (USA), Orgalutran (EU)
View DetailsMenotropins
Strength:
75 IU, 150 IU
Form: Injection
Reference Brands: Menopur (USA/EU), Repronex (USA/EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit